A leading cause of cancer deaths worldwide, colon cancer is famously resistant to treatment. There are many reasons for this, but one has to do with a group of persisting cancer cells in the colon that cause relapses. Conventional therapies against them are mostly ineffective. EPFL scientists have now identified a biological mechanism that can be exploited to counteract colon cancer relapses. The approach activates a protein that is lost in the persisting cancer cells. The researchers were able to reactivate it using vitamin A, thus eliminating the cancer cells and preventing metastasis.
The study is published in Cancer Cell, and introduces a new way to treat colon cancer.
When a colon-cancer patient receives treatment, e.g. chemotherapy, most of the cancer cells die off. But the genetic mutations that caused the cancer in the first place can survive in a specific group of cells of the colon. These are actually stem cells, meaning that they are premature cells waiting to grow into full-blown, normal cells of the colon. After cancer treatment ends, the surviving stem cells, still containing the cancerous mutations, can reappear and cause a relapse.
The lab of Joerg Huelsken at EPFL studied how differentiated colon cells come from stem cells in the gut. Using an array of different techniques, the team looked at cells, mouse models and samples from human patients.
Proteins and signaling pathways
The study focused on a protein called HOXA5, which belongs to a family of proteins that regulate the development of the fetus. These proteins are made during early development and work together to make sure that every tissue is correctly identified and that the fetus’s body and limbs are patterned properly. In the adult body, proteins like HOXA5 regulate the body’s stem cells to maintain both the identity and function of different tissues. Huelsken’s team found that in the gut, HOXA5 plays a major role in restricting the number of stem cells, as well as the cells that make them.
Like all proteins, HOXA5 originates from a specific gene. The study showed that the cancerous stem cells of the colon use a biological mechanism that blocks it. This mechanism is called a “signaling pathway” because it involves a domino of molecules, each activating the next one down the line. The purpose of a signaling pathway is to transmit biological information from one part of the cell to another, e.g. from the outer membrane all the way to the nucleus. By blocking the HOXA5 gene, the cancerous stem cells of the colon can grow uncontrollably and spread, causing relapses and metastasis.
Retinoids: a way to fight back
The researchers looked for ways to reverse the blocking of HOXA5. The answer came from vitamin A. This small chemical structure is called a retinoid, and it has been known to induce differentiation of stem cells in the skin. The EPFL scientists found that retinoids can re-activate HOXA5. In mice that had colon cancer, the treatment with retinoids blocked tumor progression and normalized the tissue. By turning the gene for HOXA5 back on, this treatment eliminated cancer stem cells and prevented metastasis in the live animals. The researchers got similar results with samples from actual patients.
The new study suggests that patients that may profit from this well-tolerated treatment can be identified based on their expression pattern for the HOXA5 gene. Retinoid differentiation therapy could be significantly effective against colon cancer, not only for treatment of existing disease but also as a preventive measure in high-risk patients.
Read more: Treating colon cancer with vitamin A
The Latest on: Treating colon cancer with vitamin A
via Google News
The Latest on: Treating colon cancer with vitamin A
- Why your cancer care team may need a gastroenterologiston February 3, 2020 at 6:58 am
system, and treating these conditions may be key to their recovery. GI specialists also assist in diagnosing and staging a breadth of diseases. Gastroenterologists are trained to treat diseases of the ...
- Cancer cell reversion may offer a new approach to colorectal cancer treatmenton February 3, 2020 at 6:33 am
The researchers plan to continue studying how to return cancer cells to healthier states, with the ultimate goal of translating their work to therapeutic treatment for patients with colorectal cancer.
- Colorectal cancer diagnoses from 49 to 50 rose 46%on February 3, 2020 at 6:32 am
requiring surgery and possibly chemotherapy and radiation treatment. The study adds fuel to the debate about whether screenings should begin at age 45. Karlitz says the combined burden of undetected ...
- These Start-Ups Are Racing to Help Doctors Detect Cancer Early With a Simple Blood Teston February 1, 2020 at 3:47 pm
If Gabriel Otte’s start-up, Freenome, is successful, millions of people could get a blood test to screen for early-stage colorectal cancer ... has been diagnosed with cancer, including how it’s ...
- Top 6 juices that help fight cancer: How to prevent cancer by drinking juiceson February 1, 2020 at 10:38 am
Tomatoes: Tomatoes are a good source of vitamin C and sodium, phosphorus, calcium, potassium, magnesium and sulfur. Tomatoes are recommended as an excellent method for the treatment of prostate ...
- Dana-Farber researcher: High-dose vitamin D can delay colorectal cancer progressionon January 18, 2020 at 3:28 pm
Advanced stage, incurable, metastatic colorectal cancer patients given high doses of vitamin D along with chemotherapy can ... in which centers across the country will be testing the treatment in 400 ...
- Antioxidant supplements linked to increased risk for breast cancer recurrence, deathon January 16, 2020 at 10:14 am
Vitamin B12, iron and omega-3 fatty acid use was also associated with poorer outcomes.” Many patients with cancer use dietary supplements during treatment. However, few data exist on the ...
- Use of Antioxidants During Chemotherapy May Increase Risk for Breast Cancer Recurrenceon January 15, 2020 at 11:14 am
Use of antioxidant supplements during chemotherapy treatment increased ... Park Comprehensive Cancer Center urged patients with breast cancer being treated with chemotherapy to consult with their ...
- Taking Supplements During Breast Cancer Treatment Increases Risk Of Death And Relapse, What Does This Mean For Patients?on January 6, 2020 at 5:40 am
A new study found that people with breast cancer who take ... would recur after treatment. The main findings were: Patients who reported taking any antioxidant - vitamins A, C, E and carotenoids ...
- Treating colon cancer with vitamin Aon December 13, 2015 at 4:00 pm
A leading cause of cancer deaths worldwide, colon cancer is famously resistant to treatment. There are many reasons for this, but one has to do with a group of persisting cancer cells in the colon ...
via Bing News